RAVMP/618645:
Ravulizumab Monitoring Panel, Serum
Test Classification Current Value
This test was developed, and its performance characteristics determined by Mayo Clinic. It has not been cleared or approved by the U.S. Food and Drug Administration.
Test Classification Value Prior to 1/11/2024 8:05pm
This test was developed, and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.